Zimmer Biomet (ZBH) PT Lowered to $145 at JMP Securities
Get Alerts ZBH Hot Sheet
Price: $99.40 -0.64%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
JMP Securities lowered its price target on Zimmer Biomet (NYSE: ZBH) to $145.00 (from $150.00) while maintaining a Market Outperform rating.
Analyst David Turkaly cuts the PT after a downward adjustment to his modeled EPS. He remains positive on the equity noting the price is inexpensive relative to peers and believes the board will be able to locate a quality candidate for the CEO role that would alleviate the challenges the company currently faces.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Kazia Therapeutics (KZIA) PT Raised to $40 at BTIG
- MiniMed Group (MMED) PT Raised to $28 at BTIG
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share